Report for: M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID

Title	M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID
Published in	Trials, April 2022
DOI	10.1186/s13063-022-06085-3
Pubmed ID	35461260
Authors	Valérie Martel-Laferrière, Daniel J. Feaster, Lisa R. Metsch, Bruce R. Schackman, Christine Loignon, Bohdan Nosyk, Hansel Tookes, Czarina N. Behrends, Nelson Arruda, Oluleye Adigun, Marie-Eve Goyer, Michael A. Kolber, Jean-Francois Mary, Allan E. Rodriguez, Iveth G. Yanez, Yue Pan, Rania Khemiri, Lauren Gooden, Aïssata Sako, Julie Bruneau

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
Unknown	3	100%

Type	Count	As %
Members of the public	2	67%
Practitioners (doctors, other healthcare professionals)	1	33%

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	48	100%

Readers by professional status	Count	As %
Student > Bachelor	5	10%
Researcher	5	10%
Student > Master	4	8%
Student > Postgraduate	3	6%
Other	2	4%
Other	3	6%
Unknown	26	54%

Readers by discipline	Count	As %
Medicine and Dentistry	7	15%
Nursing and Health Professions	5	10%
Social Sciences	3	6%
Engineering	2	4%
Pharmacology, Toxicology and Pharmaceutical Science	2	4%
Other	3	6%
Unknown	26	54%

M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID